Skip to content

Birth Control Health Center

Font Size

FDA OKs 'No-Period' Birth Control Pill

Lybrel Is 1st Oral Contraceptive Designed to Stop Menstruation

Eliminating Menstrual Cycles continued...

Normally, says Goldstein, a rise in hormones linked to ovulation causes the lining of the uterus to thicken in anticipation of a fertilized egg. If fertilization does not occur, hormone levels drop and the lining is shed in the form of menstrual blood. Oral contraceptives, however, change that activity.

"The pill shuts down your normal hormone production and replaces it with a very tiny amount, so there is no buildup of the uterine lining," says Goldstein, a professor at NYU Medical Center in New York City. Without a lining, there is no shedding, so the bleeding that occurs when you stop the pill is a "withdrawal bleed caused by a drop in hormones," explains Goldstein.

Goldstein tells WebMD that the monthly bleeding that occurs during pill use is unnecessary, so avoiding it -- the way you can with Lybrel -- should have no impact on health. Moreover, Goldstein says the menstrual cycle and fertility should return soon after stopping this pill, much the way it does with other oral contraceptives.

In at least one study conducted by Wyeth and presented at the 2006 annual meeting of the American College of Obstetricians and Gynecologists, 99% of 187 women taking Lybrel for one year either returned to menstruating or got pregnant within 90 days after stopping the drug.

Long-Term Safety Questioned

The FDA has asked Wyeth to do a postmarketing study to see if the risk of serious adverse events -- particularly blood clots -- is more common with Lybrel than with traditional contraceptives.

"We don't suspect that there are going to be any surprises in terms of long-term use of this product," Shames says.

Side effects of Lybrel are similar to other low-dose oral contraceptives, including an increased risk of blood clots, particularly in smokers and women over 35, and breakthrough bleeding.

Perhaps more importantly however, cancer experts, like NYU's Julia Smith, MD, are concerned about the lack of long-term data measuring the impact of continuous-use hormones on the risk of breast and other hormone-fueled cancers.

"This is something that has not been carefully studied yet. We don't have any evidence that there is a problem, but we certainly have many instances in the history of medicine where problems only showed up at a much later date after long-term exposure and widespread use," says Smith, director of the Lynne Cohen Breast Cancer Preventive Program at the NYU Cancer Institute.

Moreover, she tells WebMD, "When you tamper with the way the body works naturally you can't predict long-term outcome until you study long-term outcome. And right now we don't have that data."

According to spokeswoman Natalie deVane, Wyeth has conducted large clinical trials evaluating efficacy and safety for one year, with a smaller subset of women followed for a second year. For use beyond that point, they suggest women turn to their doctor for advice.

Today on WebMD

IUD
Here's what to expect.
man opening condom wrapper
Do you know the right way to use them?
 
birth control pills
Here's what to do next.
doctor and patient
His and her options.
 
Forgot To Take Your Birth Control Pills
Article
pelivic pain slideshow
Slideshow
 
Birth Control Pills Weight Gain
Article
Ortho Evra Birth Control Patch
Article
 
Comparing Birth Control Pill
Article
New Birth Control Pill
Video
 
HPV Vaccine Future
Article
Young couple holding hands
Quiz